Viewing Study NCT00121303


Ignite Creation Date: 2025-12-24 @ 7:36 PM
Ignite Modification Date: 2025-12-31 @ 7:01 AM
Study NCT ID: NCT00121303
Status: COMPLETED
Last Update Posted: 2016-09-20
First Post: 2005-07-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cytarabine and Daunorubicin With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module